Biocryst Pharmaceuticals Inc (BCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

11,865,000 $89,224,800 1.26%
2.
Kynam Capital

Derrick Tang

9,085,368 $68,321,967 4.03%
3.
Deerfield Management

James E. Flynn

8,144,442 $61,246,204 +1% 1.15%
4.
Alkeon Capital Management

Panayotis Takis Sparaggis

7,093,822 $53,345,541 0.1%
5. 3,182,617 $23,933,278 -5% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.36 7,861 Director 44,951 2024-05-30 Filing
$6.40 2,500 Director 2,500 2024-05-24 Filing
$6.38 5,000 Director 86,818 2024-05-20 Filing
$6.25 15,000 Director 66,997 2024-05-20 Filing
$5.57 36,300 Officer 266,744 2024-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.54 7,000 Director 86,638 2024-12-13 Filing
$6.32 8,600 Director 27,831 2024-06-24 Filing
$6.00 4,689 Director 27,742 2024-06-17 Filing
$6.11 6,698 Director 52,852 2024-06-14 Filing
$7.98 4,000 Director 25,611 2023-06-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 22,095,163 $166,155,623 0%
2. 21,890,422 $164,615,973 0%
3. 7,498,967 $56,392,232 0%
4. 4,823,735 $36,283,220 0%
5. 3,846,154 $29,230,770 12.83%
News See All